3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
2
Colonic Neoplasms
1
Interventions
pembrolizumab
11
Fluorouracil
10
Oxaliplatin
8
Nivolumab
7
Leucovorin
6
Cisplatin
6
Capecitabine
6
Sorafenib
5
Ipilimumab
5
Cetuximab
5
Bevacizumab
5
Irinotecan
4
trifluridine tipiracil drug combination
3
trastuzumab deruxtecan
3
durvalumab
3
cabozantinib
3
Trastuzumab
3
Paclitaxel
3
zolbetuximab
2
trametinib
2
sodium thiosulfate
2
selpercatinib
2
relatlimab
2
lenvatinib
2
larotrectinib
2
encorafenib
2
dabrafenib
2
binimetinib
2
X-Rays
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has announcements
×
HMPL-013
×
Gastrointestinal
×
Clear all
NCT04322539
2025-04-04
FRESCO-2
Hutchmed
Phase 3
Completed
691 enrolled
26 charts
1 FDA
NCT02314819
2020-02-17
FRESCO
Hutchmed
Phase 3
Completed
416 enrolled
1 FDA